BioNTech Lays Off Dozens In Gaithersburg
BioNTech has announced a significant restructure of its Gaithersburg, Maryland cell therapy operations, resulting in the layoff of 63 employees by the end of 2025. This move follows disappointing Phase I clinical trial results for its CAR-T candidate BNT211 targeting testicular cancer and germ cell tumors. Consequently, the company will wind down all cell therapy